AU2003293237A8 - Methods for reacting an antigen masking compound with red blood cells with high efficiency - Google Patents

Methods for reacting an antigen masking compound with red blood cells with high efficiency

Info

Publication number
AU2003293237A8
AU2003293237A8 AU2003293237A AU2003293237A AU2003293237A8 AU 2003293237 A8 AU2003293237 A8 AU 2003293237A8 AU 2003293237 A AU2003293237 A AU 2003293237A AU 2003293237 A AU2003293237 A AU 2003293237A AU 2003293237 A8 AU2003293237 A8 AU 2003293237A8
Authority
AU
Australia
Prior art keywords
reacting
methods
high efficiency
blood cells
red blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003293237A
Other versions
AU2003293237A1 (en
Inventor
Basha Clark
Adonis Stassinopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cerus Corp
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Publication of AU2003293237A1 publication Critical patent/AU2003293237A1/en
Publication of AU2003293237A8 publication Critical patent/AU2003293237A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0641Erythrocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2003293237A 2002-12-04 2003-12-03 Methods for reacting an antigen masking compound with red blood cells with high efficiency Abandoned AU2003293237A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US43121602P 2002-12-04 2002-12-04
US43121302P 2002-12-04 2002-12-04
US43121402P 2002-12-04 2002-12-04
US43121502P 2002-12-04 2002-12-04
US60/431,214 2002-12-04
US60/431,215 2002-12-04
US60/431,216 2002-12-04
US60/431,213 2002-12-04
PCT/US2003/038270 WO2004049914A2 (en) 2002-12-04 2003-12-03 Methods for reacting an antigen masking compound with red blood cells with high efficiency

Publications (2)

Publication Number Publication Date
AU2003293237A1 AU2003293237A1 (en) 2004-06-23
AU2003293237A8 true AU2003293237A8 (en) 2004-06-23

Family

ID=32475715

Family Applications (4)

Application Number Title Priority Date Filing Date
AU2003302499A Abandoned AU2003302499A1 (en) 2002-12-04 2003-12-03 Methods for antigen masking of red blood cells resulting in reduced hemolysis
AU2003298827A Abandoned AU2003298827A1 (en) 2002-12-04 2003-12-03 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera
AU2003293237A Abandoned AU2003293237A1 (en) 2002-12-04 2003-12-03 Methods for reacting an antigen masking compound with red blood cells with high efficiency
AU2003297614A Abandoned AU2003297614A1 (en) 2002-12-04 2003-12-03 Novel activated polyethylene glycol compounds

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AU2003302499A Abandoned AU2003302499A1 (en) 2002-12-04 2003-12-03 Methods for antigen masking of red blood cells resulting in reduced hemolysis
AU2003298827A Abandoned AU2003298827A1 (en) 2002-12-04 2003-12-03 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2003297614A Abandoned AU2003297614A1 (en) 2002-12-04 2003-12-03 Novel activated polyethylene glycol compounds

Country Status (2)

Country Link
AU (4) AU2003302499A1 (en)
WO (4) WO2004050848A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521174B2 (en) * 2003-12-05 2009-04-21 Albert Einstein College Of Medicine Of Yeshiva University Universal red blood cells, methods of preparing same, and uses thereof
CN103755949B (en) 2009-12-25 2016-04-13 天津键凯科技有限公司 Multi-arm polyethylene glycol derivative and with the binding substances of medicine and gel
IL256381B1 (en) 2015-06-26 2024-08-01 Cerus Corp Cryoprecipitate compositions and methods of preparation thereof
US10799533B2 (en) 2015-10-23 2020-10-13 Cerus Corporation Plasma compositions and methods of use thereof
MX2019010492A (en) 2017-03-03 2019-11-25 Cerus Corp Kits and methods for preparing pathogen-inactivated platelet compositions.
KR20200115498A (en) 2017-12-29 2020-10-07 세루스 코포레이션 Systems and methods for treating biological fluids
WO2020263759A2 (en) 2019-06-22 2020-12-30 Cerus Corporation Biological fluid treatment systems
JP2022539154A (en) 2019-06-28 2022-09-07 シーラス コーポレイション Systems and methods for implementing biological fluid handling devices
WO2023172180A1 (en) * 2022-03-07 2023-09-14 Icoat Medical Ab New use of peg-phospholipid molecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL292906A (en) * 1962-10-30
US6312685B1 (en) * 1998-03-13 2001-11-06 Timothy C. Fisher Red blood cells covalently bound with two different polyethylene glycol derivatives
WO2001091775A2 (en) * 2000-05-31 2001-12-06 Cerus Corporation Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity

Also Published As

Publication number Publication date
AU2003302499A8 (en) 2004-06-23
AU2003298827A1 (en) 2004-06-23
WO2004050848A3 (en) 2004-12-09
WO2004049914A2 (en) 2004-06-17
AU2003293237A1 (en) 2004-06-23
WO2004050897A3 (en) 2004-08-26
WO2004050897A2 (en) 2004-06-17
WO2004050848A2 (en) 2004-06-17
AU2003297614A8 (en) 2004-06-23
WO2004050029A2 (en) 2004-06-17
AU2003302499A1 (en) 2004-06-23
AU2003297614A1 (en) 2004-06-23
WO2004050029A3 (en) 2004-10-21
AU2003298827A8 (en) 2004-06-23
WO2004049914A3 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
AU2003249283A1 (en) High power mcm package
GB0228210D0 (en) Single chain antibodies
HUP0300324A3 (en) Hybrid compressor
AU2003903341A0 (en) Carrier for solar energy reflector element
AU2003217574A1 (en) Ejector based engines
NO20034944D0 (en) Re-activated T cells for adoptive immunotherapy
EP1335444A3 (en) Sealed prismatic battery
GB0519534D0 (en) Improvement system of energy efficiency for refrigeration cycle
EP1464089A4 (en) Hermetic seals for lithium-ion batteries
DE60216675D1 (en) Prismatic gas-tight battery module
GB0425941D0 (en) Method for increasing efficiency of thermotunnel devices
GB0205734D0 (en) Hybrid wind-hydro turbine
AU2003293237A8 (en) Methods for reacting an antigen masking compound with red blood cells with high efficiency
AU2003224637A8 (en) High performance fuel cells
GB2397450B (en) High efficiency power amplifier
AU2003271495A1 (en) Power semiconductor module
AU2003252083A1 (en) High efficiency germline transformation system
AU2003261932A1 (en) Method of analyzing protein using fluorescent resonance energy transfer
DE03791054T1 (en) Particle separator
AU2003295731A8 (en) High efficiency solar cells
GB0200751D0 (en) Hybrid photovoltaic module
AU2003302352A1 (en) Method for increasing efficiency of thermotunnel devices
AU2003283378A1 (en) Method for increasing the efficiency of natural gas
AU2002368450A1 (en) Radioablation of hemolymphopoietic cell populations
GB0209104D0 (en) Battery separators

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase